PRKAA1 and type 2 diabetes mellitus: The activation of AMPK regulated by pharmacological activators (such as metformin) is also involved in the regulation of type 2 diabetes, indicating that the regulation of AMPK activity directly interferes with the risk factors and progression of breast cancer [27].